ArticleGenetics2026
Identification of two Cryptococcus neoformans heme transporters involved in Fhb1-mediated nitrosative stress protection in a fission yeast model.
Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In Schizosaccharomyces pombe and Cryptococcus neoformans, the flavohemoglobins (flavoHbs) that protect these yeasts against nitrosative stress are Yhb1 and Fhb1, respectively. Although heme is an essential cofactor for flavoHb activity, the molecular circuitry governing the acquisition of exogenous heme by flavoHbs remains largely unknown. Because S. pombe is a powerful model organism for studying heme biology, Fhb1 was heterologously expressed in S. pombe mutant cells lacking Yhb1. Fhb1 expression functionally complements yhb1Δ cells that are defective in nitric oxide (˙NO) detoxification. Moreover, this Fhb1-mediated complementation requires the S. pombe heme transporter Str3 or the heterologous coexpression of two previously uncharacterized C. neoformans transporters, CnStr1 and CnStr3. Consistent with this finding, heterologous expression of CnStr1 and CnStr3 rescues the heme-dependent growth defect of S. pombe cells that are deficient in heme biosynthesis and lack endogenous heme uptake systems when hemin is provided as the sole heme source. Coimmunoprecipitation assays further demonstrate interactions between Fhb1 and S. pombe Str3 or C. neoformans Str3-like proteins when coexpressed in fission yeast cells. In C. neoformans, strains lacking CnStr1 and CnStr3 exhibit a heme-dependent growth defect in the absence of the cell-surface hemophore Cig1. Similar to the C. neoformans fhb1Δ mutant, a cig1Δ Cnstr1Δ Cnstr3Δ triple mutant fails to protect cells from nitrosative stress. Collectively, these findings reveal functional conservation between S. pombe Yhb1 and C. neoformans Fhb1 in their ability to acquire exogenous heme required for activation as defenders against nitrosative stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.